Contracts › W81XWH21C0075
W81XWH21C0075: FY20 New Start-JW200215-IMPROVING Neurotrauma By Depolarization Inhibition With Combination Therapy (INDICT): a Phase 2 Randomized Trial
Awarded to Cincinnati Univ of by Department of the Army.
$4.4Mobligated
$4.4Mpotential value
20 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | W81XWH21C0075 |
|---|---|
| Awardee | Cincinnati Univ of |
| Awarding agency | Department of the Army |
| Awarding office | W4PZ USA MED RSCH ACQUIS ACT |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | OH |
| Offers received | 1 |
| Period of performance | 21 September 2021 to 20 September 2026 |
| Potential end | 20 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record